<DOC>
	<DOCNO>NCT02393040</DOCNO>
	<brief_summary>The purpose study determine efficacy treatment Platelet-rich plasma Androgenetic alopecia ( compare placebo ) , six month baseline .</brief_summary>
	<brief_title>Study Assess Efficacy Platelet-Rich Plasma Androgenetic Alopecia</brief_title>
	<detailed_description>Androgenetic alopecia ( AGA ) non-scarring pattern alopecia , multifactorial genetic determine skin condition . This pathology one common form progressive hair loss . It 's increasingly frequent complaint dermatology clinic patient high impact psychologically . The onset AGA gradual pathology progress , anagen phase shorten telogen phase remain constant . As result , hair telogen phase , patient may notice increase hair shed . This area vary patient patient usually mark vertex men woman androgenetic alopecia generally lose hair diffusely crown . The incidence prevalence AGA increase age . Topical minoxidil oral finasteride gold standard therapy AGA two drug currently US Food Drug Administration ( FDA ) -approved indication treatment androgenetic alopecia . Minoxidil finasteride know effective medical treatment AGA , especially initial grade . PRP plasma concentrate reap patient 's whole blood comprises predominantly platelet . Numerous growth factor ( GFs ) present within platelet α granule . Some important include platelet-derived growth factor ( PDGF ) , transform growth factor-beta ( TGF-β ) , vascular endothelial growth factor ( VEGF ) , epidermal growth factor ( EGF ) , insulin-like growth factor ( IGF ) . This GFs stimulate cell proliferation differentiation . PRP identify beneficial effect bone graft application oral maxillofacial surgery , orthopedic cardiac surgery . More recently , increase interest see application PRP dermatology , example , tissue regeneration , wound heal fat grafting . It also show promote hair survival growth , vitro vivo . The production autologous PRP involve extraction specific volume patient 's whole blood , place automate centrifuge separate layer whole blood specific weight 3 separate layer : ( 1 ) platelet-poor plasma , ( 2 ) platelet-rich plasma ( 3 ) red blood cell . The patient divide two group ( A B ) : group A receive treatment PRP right half-head placebo leave half-head , whereas group B receive treatment PRP leave half-head placebo right half-head .</detailed_description>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<criteria>Patients ≥18 year &lt; 65 year Male patient clinical diagnosis AGA ( stage II V accord HamiltonNorwood Scale ) Female patient clinical diagnosis AGA ( stage I III accord Ludwig Classification ) Patients type alopecia , AGA Fasting &lt; 3h prior injection Use nonsteroidal antiinflammatory drug one week treatment . Platelet count &lt; 150 000 μL Alterations coagulation Heavy smoker ( &gt; 20 cigarettes/day ) Medications : anticoagulants/ acetylsalicylic acid Patient unable accomplish fas treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Alopecia</keyword>
	<keyword>Androgenetic Alopecia</keyword>
	<keyword>Alopecia , Male Pattern</keyword>
	<keyword>Hair loss</keyword>
	<keyword>Platelet-Rich Plasma</keyword>
	<keyword>Alopecia , Female Pattern</keyword>
	<keyword>placebo</keyword>
	<keyword>double-blind</keyword>
</DOC>